Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor subfamily 2 group F member 1 (NR2F1), also known as COUP transcription factor 1 (COUP-TFI), is a highly conserved orphan nuclear receptor and transcription factor that binds specific DNA motifs to regulate the expression of multiple genes during embryonic and neural development[1][2][3][5]. NR2F1 functions as a master regulator in neural progenitor cell proliferation, differentiation, and migration, and it is essential for regional identity acquisition in developing cerebral cortex and visual system[3][5]. Its activity can act as a gene activator or repressor depending on context, typically involving chromatin remodeling and interaction with co-activators or co-repressors[3]. Mutations in NR2F1 cause Bosch-Boonstra-Schaaf optic atrophy syndrome in humans and are implicated in multiple other neurodevelopmental and cancer-associated roles[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor subfamily 2 group F member 1 (NR2F1).